From Covid to Norovirus: Moderna’s mRNA Tech Takes on Stomach Flu
Moderna's Phase III trial will test out its experimental vaccine in 25,000 people over the next two years.
Moderna's Phase III trial will test out its experimental vaccine in 25,000 people over the next two years.